Literature DB >> 7930415

Pulmonary function in spinal muscular atrophy.

F J Samaha1, C R Buncher, B S Russman, M L White, S T Iannaccone, L Barker, K Burhans, C Smith, B Perkins, L Zimmerman.   

Abstract

We present the first prospective study on pulmonary function in spinal muscular atrophy patients. Seventy-seven spinal muscular atrophy patients, ages 5 to 18 years, from three centers, were studied with regard to forced vital capacity, using height as a predictor. Patients were categorized into four motor function categories. The highest-functioning group had normal or near-normal values, and those who sat with support had the lowest values. Those with intermediate function had intermediate values. Forced vital capacity was studied longitudinally in 40 spinal muscular atrophy patients for 1.1 to 4.4 years. Eighty-eight percent of patients grew in height, but only 35% showed an increase in height-adjusted forced vital capacity percent. In those patients with the least function, 100% lost height-adjusted forced vital capacity over time. In those patients with the highest function, 57% lost height-adjusted forced vital capacity. In addition, the basic forced vital capacity, not correlated to height, decreased in 43% of cases. These pulmonary function alterations appear to be important determinants for function and survival in spinal muscular atrophy patients.

Entities:  

Mesh:

Year:  1994        PMID: 7930415     DOI: 10.1177/088307389400900321

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  8 in total

1.  Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy.

Authors:  J Montes; M P McDermott; W B Martens; S Dunaway; A M Glanzman; S Riley; J Quigley; M J Montgomery; D Sproule; R Tawil; W K Chung; B T Darras; D C De Vivo; P Kaufmann; R S Finkel
Journal:  Neurology       Date:  2010-03-09       Impact factor: 9.910

2.  Physical exercise reduces cardiac defects in type 2 spinal muscular atrophy-like mice.

Authors:  Olivier Biondi; Philippe Lopes; Céline Desseille; Julien Branchu; Farah Chali; Amina Ben Salah; Claude Pariset; Christophe Chanoine; Frédéric Charbonnier
Journal:  J Physiol       Date:  2012-08-28       Impact factor: 5.182

3.  CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy.

Authors:  Marco A Passini; Jie Bu; Eric M Roskelley; Amy M Richards; S Pablo Sardi; Catherine R O'Riordan; Katherine W Klinger; Lamya S Shihabuddin; Seng H Cheng
Journal:  J Clin Invest       Date:  2010-03-15       Impact factor: 14.808

4.  Real-World Data on Access to Standards of Care for People With Spinal Muscular Atrophy in the UK.

Authors:  Robert Muni-Lofra; Lindsay B Murphy; Kate Adcock; Maria E Farrugia; Joseph Irwin; James B Lilleker; John McConville; Andria Merrison; Matt Parton; Liz Ryburn; Mariacristina Scoto; Chiara Marini-Bettolo; Anna Mayhew
Journal:  Front Neurol       Date:  2022-05-30       Impact factor: 4.086

Review 5.  Spinal muscular atrophy.

Authors:  Susan T Iannaccone; Stephen A Smith; Louise R Simard
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

6.  Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Authors:  Justin C DeVanna; Joe N Kornegay; Daniel J Bogan; Janet R Bogan; Jennifer L Dow; Eleanor C Hawkins
Journal:  Neuromuscul Disord       Date:  2013-10-24       Impact factor: 4.296

7.  Natural history of lung function in spinal muscular atrophy.

Authors:  Camiel A Wijngaarde; Esther S Veldhoen; Ruben P A van Eijk; Marloes Stam; Louise A M Otto; Fay-Lynn Asselman; Roelie M Wösten-van Asperen; Erik H J Hulzebos; Laura P Verweij-van den Oudenrijn; Bart Bartels; Inge Cuppen; Renske I Wadman; Leonard H van den Berg; Cornelis K van der Ent; W Ludo van der Pol
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

8.  SMA-MAP: a plasma protein panel for spinal muscular atrophy.

Authors:  Dione T Kobayashi; Jing Shi; Laurie Stephen; Karri L Ballard; Ruth Dewey; James Mapes; Brett Chung; Kathleen McCarthy; Kathryn J Swoboda; Thomas O Crawford; Rebecca Li; Thomas Plasterer; Cynthia Joyce; Wendy K Chung; Petra Kaufmann; Basil T Darras; Richard S Finkel; Douglas M Sproule; William B Martens; Michael P McDermott; Darryl C De Vivo; Michael G Walker; Karen S Chen
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.